Observational Study of Patient with frequent COPD Exacerbations

Trial Identifier: D5980R00123
Sponsor: AstraZeneca
Start Date: December 2024
Primary Completion Date: June 2026
Study Completion Date: June 2026
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Ekaterinburg, Russia
Russia Ivanovo, Russia
Russia Moscow, Russia
Russia St. Petersburg, Russia
Russia Voronezh, Russia